No retraction, correction or concern found when last checked on Nov 2, 2026.

Long-term effects of PM2·5 on neurological disorders in the American Medicare population: a longitudinal cohort study

Liuhua Shi, Xiao Wu, Mahdieh Danesh Yazdi and 10 more

The Lancet Planetary Health · 2020 · CC BY-NC-ND

Abstract

Background Accumulating evidence links fine particulate matter (PM 2·5 ) to premature mortality, cardiovascular disease, and respiratory disease. However, less is known about the influence of PM 2·5 on neurological disorders. We aimed to investigate the effect of long-term PM 2·5 exposure on development of Parkinson's disease or Alzheimer's disease and related dementias. Methods We did a longitudinal cohort study in which we constructed a population-based nationwide open cohort including all fee-for-service Medicare beneficiaries (aged ≥65 years) in the contiguous United States (2000–16) with no exclusions. We assigned PM 2·5 postal code (ie, ZIP code) concentrations based on mean annual predictions from a high-resolution model. To accommodate our very large dataset, we applied Cox-equivalent Poisson models with parallel computing to estimate hazard ratios (HRs) for first hospital admission for Parkinson's disease or Alzheimer's disease and related dementias, adjusting for potential confounders in the health models. Findings Between Jan 1, 2000, and Dec 31, 2016, of 63 038 019 individuals who were aged 65 years or older during the study period, we identified 1·0 million cases of Parkinson's disease and 3·4 million cases of Alzheimer's disease and related dementias based on primary and secondary diagnosis billing codes. For each 5 μg/m 3 increase in annual PM 2·5 concentrations, the HR was 1·13 (95% CI 1·12–1·14) for first hospital admission for Parkinson's disease and 1·13 (1·12–1·14) for first hospital admission for Alzheimer's disease and related dementias. For both outcomes, there was strong evidence of linearity at PM 2·5 concentrations less than 16 μg/m 3 (95th percentile of the PM 2·5 distribution), followed by a plateaued association with increasingly larger confidence bands. Interpretation We provide evidence that exposure to annual mean PM 2·5 in the USA is significantly associated with an increased hazard of first hospital admission with Parkinson's disease and Alzheimer's disease and related dementias. For the ageing American population, improving air quality to reduce PM 2·5 concentrations to less than current national standards could yield substantial health benefits by reducing the burden of neurological disorders. Funding The Health Effects Institute, The National Institute of Environmental Health Sciences, The National Institute on Aging, and the HERCULES Center.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 34

1.
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2019
No notice
2.
Maragakis NJ, Rothstein JD. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006; 2: 679–89.
Not in our library10.1038/ncpneuro0355
3.
Ailshire J, Karraker A, Clarke P. Neighborhood social stressors, fine particulate matter air pollution, and cognitive function among older U.S. adults. Soc Sci Med 2017; 172: 56–63.
Not in our library10.1016/j.socscimed.2016.11.019
4.
Long-Term Air Pollution and Traffic Noise Exposures and Mild Cognitive Impairment in Older Adults: A Cross-Sectional Analysis of the Heinz Nixdorf Recall Study · 2016
No notice
5.
Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models · 2017
No notice
6.
Weuve J, Puett RC, Schwartz J, Yanosky JD, Laden F, Grodstein F. Exposure to particulate air pollution and cognitive decline in older women. Arch Intern Med 2012; 172: 219–27.
Not in our library10.1001/archinternmed.2011.683
7.
Lee M, Schwartz J, Wang Y, Dominici F, Zanobetti A. Long-term effect of fine particulate matter on hospitalization with dementia. Environ Pollut 2019; 254: 112926.
Not in our library10.1016/j.envpol.2019.07.094
8.
Chen H, Kwong JC, Copes R, Living near major roads and the incidence of dementia, Parkinson’s disease, and multiple sclerosis: a population-based cohort study. Lancet 2017; 389: 718–26.
Not in our library10.1016/s0140-6736(16)32399-6
9.
Long-term PM2.5 Exposure and Neurological Hospital Admissions in the Northeastern United States · 2015
No notice
10.
Bondy SC. Anthropogenic pollutants may increase the incidence of neurodegenerative disease in an aging population. Toxicology 2016; 341–343: 41–46.
Not in our library10.1016/j.tox.2016.01.007
11.
Calderón-Garcidueñas L, Solt AC, Henríquez-Roldán C, Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid β−42 and α-synuclein in children and young adults. Toxicol Pathol 2008; 36: 289–310.
Not in our library10.1177/0192623307313011
12.
Block ML, Elder A, Auten RL, The outdoor air pollution and brain health workshop. Neurotoxicology 2012; 33: 972–84.
Not in our library10.1016/j.neuro.2012.08.014
13.
Bhatt DP, Puig KL, Gorr MW, Wold LE, Combs CK. A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain. PLoS One 2015; 10: e0127102.
Not in our library10.1371/journal.pone.0127102
14.
Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease · 2011
No notice
15.
Mosconi L, Tsui WH, Herholz K, Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 2008; 49: 390–98.
Not in our library10.2967/jnumed.107.045385
16.
Di Q, Amini H, Shi L, An ensemble-based model of PM2·5 concentration across the contiguous United States with high spatiotemporal resolution. Environ Int 2019; 130: 104909.
Not in our library10.1016/j.envint.2019.104909
17.
Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement 2015; 11: 718–26.
Not in our library10.1016/j.jalz.2015.05.016
18.
Wirdefeldt K, Adami H-O, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 2011; 26 (suppl 1): S1–58.
Not in our library10.1007/s10654-011-9581-6
19.
Andersen PK, Gill RD. Cox’s regression model for counting processes: a large sample study. Ann Stat 1982; 10: 1100–20.
Not in our library
20.
Bickel PJ, Götze F, van Zwet WR. Resampling fewer than n observations: gains, losses, and remedies for losses. Statistica Sinica 1997; 7: 1.
Not in our library
21.
Forman DE, Berman AD, McCabe CH, Baim DS, Wei JY. PTCA in the elderly: the “young-old” versus the “old-old”. J Am Geriatr Soc 1992; 40: 19–22.
Not in our library10.1111/j.1532-5415.1992.tb01823.x
22.
Liu R, Young MT, Chen J-C, Kaufman JD, Chen H. Ambient air pollution exposures and risk of Parkinson disease. Environ Health Perspect 2016; 124: 1759–65.
Not in our library10.1289/ehp135
23.
Kirrane EF, Bowman C, Davis JA, Associations of ozone and PM2.5 concentrations with Parkinson’s disease among participants in the Agricultural Health Study. J Occup Environ Med 2015; 57: 509–17.
Not in our library10.1097/jom.0000000000000451
24.
Liu S-Y, Chan P, Stoessl AJ. The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system. Transl Neurodegener 2017; 6: 4.
Not in our library10.1186/s40035-017-0074-8
25.
Tschanz JT, Corcoran CD, Schwartz S, Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry 2011; 19: 532–42.
Not in our library10.1097/jgp.0b013e3181faec23
26.
Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 2008; 1147: 93–104.
Not in our library10.1196/annals.1427.023
27.
Glial contributions to neurodegeneration in tauopathies · 2017
No notice
28.
Gonet T, Maher BA. Airborne, vehicle-derived fe-bearing nanoparticles in the urban environment: a review. Environ Sci Technol 2019; 53: 9970–91.
Not in our library10.1021/acs.est.9b01505
29.
Shrestha LB. Life expectancy in the United States. Congressional Information Service, Library of Congress, 2005 https://www.everycrsreport.com/files/20050303_RL32792_ca5374f4af13937c82f8749ffee41be74a3f5909.pdf (accessed Oct 2, 2020).
Not in our library
30.
Noyes K, Liu H, Holloway R, Dick AW. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord 2007; 22: 509–14.
Not in our library10.1002/mds.21299
31.
Taylor DH Jr, Østbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis 2009; 17: 807–15.
Not in our library10.3233/jad-2009-1099
32.
Exposure measurement error in PM2.5 health effects studies: A pooled analysis of eight personal exposure validation studies · 2014
No notice
33.
Weisskopf MG, Webster TF. Trade-offs of personal vs. more proxy exposure measures in environmental epidemiology. Epidemiology 2017; 28: 635–43.
Not in our library10.1097/ede.0000000000000686
34.
Turner MC, Jerrett M, Pope CA 3rd, Long-term ozone exposure and mortality in a large prospective study. Am J Respir Crit Care Med 2016; 193: 1134–42.
Not in our library10.1164/rccm.201508-1633oc

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.